SARS-CoV-2 IgM (R) Control Material for In Vitro Diagnostic Performance Verification

SARS-CoV-2 IgM (R) Control Material for In Vitro Diagnostic Performance Verification

The SARS-CoV-2 IgM (R) Control Material is intended for use in verifying the functional performance characteristics of an in vitro diagnostic medical device. It is designed to be used with the reagent kit for the determination of IgM antibodies to the SARS-CoV-2 strain using the immunochemiluminescent method.

Kit Contents:

• SARS-CoV-2 IgM (R) Control Material – 0.5 ml in each of 3 vials
• Instructions for Use
• Certificate of Target Values

Available Configurations:

• SARS-CoV-2 IgM (R) Control Material – 0.5 ml in each of 3 vials
• SARS-CoV-2 IgM (R) Control Material – 0.5 ml in each of 6 vials

Each configuration includes the Instructions for Use and the Certificate of Target Values.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, SARS-CoV-2 IgM (R) Control Material for In Vitro Diagnostic Performance Verification, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.